was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Director, Procurement North America The Procurement Director, North America is at the forefront of driving GSK’s purpose to unite science, technology, and talent to get ahead of disease together, hand in hand with leaders across the Comme...
Business Introduction The ability to understand market dynamics and brand positioning is critical to the future success of our brands. The way we integrate marketing strategies into execution plans has become a significant part of our ove...
Job Purpose As a Scientific Leader in the Complex Models group within the Respiratory, Immunology & Inflammation Biology Unit (RIIBU), you will lead the design and execution of in vivo strategy for preclinical projects and potentially for...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 milli...
We manufacture and supply reliable, high‑quality medicines to meet patients’ needs and drive performance. Our network of manufacturing partners and sites deliver medicines globally — and packaging technology is critical to ensuring product ...
We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 milli...